• Melanie Neagley, Alexis Helsel, Regina Buachie, Tracy Behrsing, Sagar Ghosh, Gayle Vaday, and Melissa D Cunningham.
• Congressionally Directed Medical Research Programs (CDMRP), U.S. Army Medical Research and Development Command (USAMRDC), Fort Detrick, MD 21702, USA.
• Mil Med. 2023 Jul 22; 188 (7-8): 190194190-194.

AbstractNearly a billion dollars is spent annually in the Military Health System (MHS) on cancer diagnosis and treatment, with a large portion of that directed toward breast, prostate, and ovarian cancers. Multiple studies have demonstrated the impact of specific cancers on MHS beneficiaries and Veterans, highlighting the fact that active duty and retired military members have a higher incidence than the general public for many chronic diseases and certain forms of cancer. The Congressionally Directed Medical Research Programs have supported research that has contributed to the development, clinical testing, and commercialization of 11 cancer drugs approved by the Food and Drug Administration to treat breast, prostate, or ovarian cancers. In addition to hallmark funding mechanisms that prioritize innovative, groundbreaking ideas, the Congressionally Directed Medical Research Program's cancer programs continue to identify new approaches to fill critical gaps across the full research spectrum, including bridging the translational research gap toward developing new treatments for cancer patients in the MHS and in the general American public.Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2023. This work is written by (a) US Government employee(s) and is in the public domain in the US.

34 keywords...

hide…